Correspondence 0001193125-23-205016 from Minerva Neurosciences, Inc. (NERV)
Minerva Neurosciences, Inc.
Date: Aug. 7, 2023 · CIK: 0001598646 · Accession: 0001193125-23-205016
AI Filing Summary & Sentiment
File numbers found in text: 333-273686
Show Raw Text
CORRESP 1 filename1.htm CORRESP August 7, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Jimmy McNamara Re: Minerva Neurosciences, Inc. Registration Statement on Form S-3 File No. 333-273686 Acceleration Request Requested Date: August 9, 2023 Requested Time: 4:00 PM Eastern Daylight Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. : 333-273686) (the “Registration Statement”) to become effective on Wednesday, August 9, 2023 at 4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Ryan S. Sansom of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Ryan S. Sansom of Cooley LLP, counsel to the Registrant, at (617) 937-2335. Very truly yours, Minerva Neurosciences, Inc. By: /s/ Frederick Ahlholm Frederick Ahlholm Chief Financial Officer cc: Remy Luthringer, Chief Executive Officer, Minerva Neurosciences, Inc. Geoff Race, President, Minerva Neurosciences, Inc. Marc Recht, Cooley LLP Ryan S. Sansom, Cooley LLP